FNY Investment Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-65,364
Closed -$2.32M 697
2022
Q2
$2.32M Buy
+65,364
New +$3.35M 1.71% 14
2019
Q1
Sell
-688
Closed -$33K 757
2018
Q4
$33K Buy
688
+531
+338% +$30.2K 0.01% 311
2018
Q3
$9K Buy
157
+34
+28% +$2.07K ﹤0.01% 543
2018
Q2
$6K Buy
+123
New +$6.15K ﹤0.01% 560

Other funds holding EHC

FNY Investment Advisers's EHC Position: Q3 2022 in Review

FNY Investment Advisers sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 65,364 shares — an estimated $2.32M sold.

FNY Investment Advisers first reported a position in EHC in Q2 2018 and held it in 4 quarters. The position peaked at $2.32M in Q2 2022. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • FNY Investment Advisers reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 65,364 Encompass Health shares in Q3 2022, an estimated $2.32M.
  • FNY Investment Advisers first reported a position in Encompass Health in Q2 2018 and held it in 4 quarters.
  • FNY Investment Advisers's Encompass Health position peaked at $2.32M in Q2 2022.
  • 346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.